Register for Your Free Live Webcast Now:

"MM+M Convene: Media"

In the future, medical care will be more personalized to individual patients’ needs. Helping to facilitate that new vision? Digital health and more virtual opportunities to reach patients where they are.

As new platforms become ad-supported models, pharma marketers can play a meaningful role in educating patients and enhancing their experience.

Within the new media landscape, marketers can provide more personalized messages that address patients' needs. This can give direction to patients who feel lost about options; help patients feel seen within the larger healthcare system; and engage them and their doctors in shared decision-making. By reaching targeted audiences through better segmentation on streaming, podcasts and digital health, marketers can get patients the information they need to actively support their health and wellness.

The healthcare and pharma marketing world continues to diversify its media mix. COVID-19 propelled the use of podcasts as a platform of choice in 2020, and in 2021 the industry began to embrace streaming as well. This MM+M event takes a look at the wealth of opportunities these platforms offer for reaching qualified consumers and better understanding how they use devices to consume health content. 

Session 1: 12pm - 12:40pm ET

Sponsored by 81qd

Everything Everywhere All Omnichannel: Leveraging Analytics to Optimize Omnichannel

As biopharma moves to Omnichannel 3.0, significant opportunity exists to leverage analytics to optimize engagement. This webinar will focus on best practices and present cases to illustrate how to utilize RWD and analytics to support omnichannel targeting and execution.

Speakers:

• Susan Abedi
  Chief strategy officer 
  Medical Knowledge Group - 81qd

• Alison Reichert
  Former head of digital and omnichannel marketing
  US Oncology, Takeda Oncology

Session 2: 12:45pm - 1:25pm ET

Sponsored by Emerging Networks 

Multicultural Marketing: Pharma’s Unexplored Frontier

High-risk ethnic segments represent an unprecedented opportunity for growth and the chance for pharma to effect positive change.

The panel will discuss:

• The gross overindexing of ethnic segments in numerous life-threatening conditions
• The apparent blind spot in pharmaceutical marketing efforts that fail to reach these ethnic segments
• The lack of oversight by government agencies in terms of how and to whom new medicines are marketed (and their unwillingness to do anything about it)
• The potential to effect positive change on all fronts, including saving lives, ensuring that all Americans are made aware of lifesaving new drugs and, ultimately, opening a new avenue of growth in the pharmaceutical industry

Speakers:

• Tom Marsillo
  CEO, Emerging Networks

• Rahul Walia
  CEO, Touchdown Media

• Dr. Omar Lattouf
  President, Life Sciences Academy
  Former president, NAAMA

• Dr. Sanjay Gupta
  Member, APPI

• Dr. Maria Alfaro
  Chief medical officer and medical director
  Noble Quest Health Foundation

• Mike Lawler
  Congressman

Offered Free by: MM+M
See All Resources from: MM+M